stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Return on assets
STERIS plc's return on assets over the twelve months to 30 September 2026 was 7.83%, up 0.3 percentage points from fiscal 2026 (7.49%). Over the past ten years it has ranged from 0.96% (fiscal 2023) to 7.75% (fiscal 2020); the current reading is higher than 92% of that period. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 7.49% | 1.69 |
| FY2025 | 5.80% | 2.34 |
| FY2024 | 3.46% | 2.50 |
| FY2023 | 0.96% | (1.75) |
| FY2022 | 2.71% | (3.90) |
| FY2021 | 6.61% | (1.14) |
| FY2020 | 7.75% | 1.84 |
| FY2019 | 5.91% | 0.16 |
| FY2018 | 5.75% | 3.61 |
| FY2017 | 2.14% | (0.84) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.4% |
| GMED Globus Medical, Inc. compare | 10.5% |
| PEN Penumbra, Inc. compare | 8.33% |
| STE STERIS plc | 7.83% |
| GEHC GE HealthCare Technologies Inc. compare | 5.78% |
| PHG Koninklijke Philips N.V. compare | 3.49% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.26% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| GKOS Glaukos Corporation compare | −17.2% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement